Tethys Bioscience Raises $25 Million
Tethys Bioscience, an Emeryville, Calif.-based developer of multi-biomarker technology, has raised $25 million in Series D funding. Capital AG led the round, and was joined by Wasatch Advisors and return backers Mohr Davidow Ventures, Kleiner Perkins Caulfield & Byers and Intel Capital. It had previously raised around $54 million.
9 November 2009•3 mins read
